Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenomyosis × Ascorbic Acid × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 14 Neoplasms 10 Multiple Myeloma 9 Colorectal Neoplasms 8 Myelodysplastic Syndromes 5 Leukemia, Myeloid, Acute 5 Glioblastoma 5 Prostatic Neoplasms 4 Neoplasms, Plasma Cell 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma 3 Leukemia, Myelomonocytic, Chronic 3 Breast Neoplasms 3 Stomatitis 2 Stomach Neoplasms 2 Skin Neoplasms 2 Ovarian Neoplasms 2 Neoplasms by Site 2 Myofibroma 2 Lymphoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Inflammation 2 Glioma 2 Digestive System Neoplasms 2 Digestive System Diseases 2 Colonic Neoplasms 2 Anemia 2 Adenocarcinoma 2 Uterine Neoplasms 1

Interventions

Uterine Artery Embolization 2 ramosetron 1 Uterine Myomectomy 1 Triamcinolone Acetonide 1 Triamcinolone 1 Surveys and Questionnaires 1 Salpingectomy 1 Saline Solution 1 Iohexol 1 Incidence 1 Ibuprofen 1 High-Energy Shock Waves 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1 Bupivacaine 1 Ascorbic Acid 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07335432 2026-01-13

Vit C in TAH

Queen Savang Vadhana Memorial Hospital, Thailand

Phase NA Enrolling by invitation

Hemorrhage, Myofibroma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡